3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Conditions
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Intraepithelial Lesions
1
Soft Tissue Neoplasms
1
Radiodermatitis
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Mucositis
1
HIV Infections
1
Endometrial Neoplasms
1
Eczema
1
Dermatitis
1
Cicatrix
1
Cancer Pain
1
Interventions
Radiotherapy
6
Fibroblast Growth Factor 7
4
Injections
3
Drug Therapy
3
Cisplatin
3
Water
2
Propolis
2
Mouthwashes
2
Morphine
2
Methotrexate
2
Melphalan
2
Low-Level Light Therapy
2
Interleukin 1 Receptor Antagonist Protein
2
Gabapentin
2
Cryotherapy
2
peppermint oil
1
pegaspargase
1
oxycodone-acetaminophen
1
nelarabine
1
kang-lai-te
1
glucarpidase
1
fludarabine phosphate
1
fish oil triglycerides
1
cyclohexaneacetic acid
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
acetaminophen, hydrocodone drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Mucositis
×
Laser Therapy
×
Clear all
NCT02696408
2020-01-29
STOP MUCITES
Institut de Cancérologie de la Loire
Phase 3
Completed
234 enrolled